Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 12/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.48 |
| ▸ | LSS | P48449 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formic Acid SCHEMBL5570521 | 1.00 | DNM1 (0.52) | DNM1HTTSLC22A1LSSKMT2A | |
| Formic Acid SCHEMBL15732741 | 1.00 | DNM1 (0.52) | DNM1HTTSLC22A1LSSKMT2A | |
| Formic Acid SCHEMBL5574352 | 1.00 | DNM1 (0.52) | DNM1HTTSLC22A1LSSKMT2A | |
| Formic Acid SCHEMBL5574272 | 0.98 | DNM1 (0.48) | DNM1HTTSLC22A1LSSKMT2A | |
| Tributylmethylammonium SCHEMBL557488 | 0.90 | SLC22A1 (0.41) | DNM1HTTSLC22A1 | |
| Formic Acid SCHEMBL5574345 | 0.86 | LSS (0.52) | DNM1HTTSLC22A1LSSKMT2A | |
| Formic Acid SCHEMBL5570529 | 0.86 | DNM1 (0.71) | DNM1HTTSLC22A1KMT2A | |
| Formic Acid SCHEMBL2533294 | 0.86 | DNM1 (0.71) | DNM1HTTSLC22A1KMT2A | |
| Formic Acid SCHEMBL5570517 | 0.86 | LSS (0.52) | DNM1HTTSLC22A1LSSKMT2A | |
| Formic Acid SCHEMBL558269 | 0.86 | DNM1 (0.71) | DNM1HTTSLC22A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9428438-B2 | Process for preparing formic acid | BASF SE (DE) | 2016-08-30 | — | — | US | disclosed |
| US-20140148617-A1 | PROCESS FOR PREPARING FORMIC ACID | BASF SE (DE) | 2014-05-29 | — | — | US | disclosed |
| US-7306013-B2 | Fuel hose | TOKAI RUBBER INDUSTRIES, LTD. (JP) | 2007-12-11 | — | — | US | disclosed |
| US-20060042712-A1 | Fuel hose | TOKAI RUBBER INDUSTRIES, LTD. (JP) | 2006-03-02 | — | — | US | disclosed |
| EP-1209175-A1 | FLUOROELASTOMER AND VULCANIZED MOLDING | Daikin Industries, Ltd. (JP) | 2002-05-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140148617-A1 | PROCESS FOR PREPARING FORMIC ACID | MSMO1, FEN1, MED1 | DNM1 136/4885HTT 3346/4885SLC22A1 3472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.